Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio

MARKSANS PHARMA. Quarterly Results  (TCPH)



Here are the latest quarterly results of MARKSANS PHARMA.. For more details, see the MARKSANS PHARMA. financial fact sheet and MARKSANS PHARMA. share price. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

MARKSANS PHARMA. Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-24
*
3
Sep-24
*
3
Dec-24
*
3
Mar-25
*
3
Jun-25
*
3
Sep-25
*
3
Dec-25
*
3
Mar-26
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m5,9066,4196,8187,0856,2007,2047,5448,561 
Other income Rs m149-136115356216201352 
Turnover Rs m6,0566,4197,1807,2386,2567,4207,7468,913 
Expenses Rs m4,6224,9515,5135,8155,1995,7595,9376,607 
Gross profit Rs m1,2841,4681,3051,2691,0011,4451,6071,954 
Depreciation Rs m204195207227231269243243 
Interest Rs m2926273461585963 
Profit before tax Rs m1,2001,2461,4331,1617661,3331,5062,000 
Tax Rs m310268382254184342369510 
Profit after tax Rs m8919781,0519075829911,1371,490 
Gross profit margin %21.722.919.117.916.120.121.322.8 
Effective tax rate %25.821.526.721.924.025.624.525.5 
Net profit margin %15.115.215.412.89.413.815.117.4 
Diluted EPS Rs 2.0 2.2 2.3 2.0 1.3 2.2 2.5 3.3  
Diluted EPS (TTM) Rs 7.4 7.7 8.2 8.4 7.8 7.8 8.0 9.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster


 

Today's Market

Sensex Today Ends 188 Points Lower | Nifty Below 24,450 | Godrej Consumer Products Down 11%(Closing)

Although the benchmark indices opened lower, they traded negative throughout the session and ultimately closed red.